What is the regional analysis of Atorvastatin API Market?
Atorvastatin API Market Highlights The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023. The atorvastatin API market size is anticipated to reach USD 2,852.3 Million by 2030 at 7.50% CAGR during the forecast period 2022-2030. North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2022 to 2030. Atorvastatin API Market Segmentation The atorvastatin API market outlook has been studied extensively by MRFR experts, with respect to applicat...